Abstract
The progression through the cell cycle is monitored by positive and negative regulators. One family of negative regulators has been reported to act as cyclin-dependent kinase inhibitors (CKI) (1–3); and these, in turn, have been subdivided into two groups on the basis of sequence homology. The first CKI family includes p21 Cip1 (4–6), p27 Kip1 (7–9), and p57 Kip2 (10,11). The other CKI subgroup includes four members: p16 INK4A/MTS1/CDKN2A (12,13), p15 INK4B/MTS2/CDKN2B (14), p18 INK4C (15), and p19 INK4D (16). The INK4A and INK4B genes map to the short arm of chromosome 9 (9p21), where they are found in tandem spanning a region of approx 80 kilobases (kb) (Fig. 1). The INK4A and the INK4B genes encode for the p16 and the p15 proteins, respectively (12–14). These protein products form binary complexes exclusively with Cdk4 and Cdk6, inhibiting their function and, by doing so, inhibiting pRB phosphorylation during G1. Additional complexity results from the presence of a second INK4A product, termed p19 ARF or p14 ARF in humans (ARF is the acronym for alternative reading frame) (17–20) (Fig. 1). The p19 ARF blocks the mdm2-induced p53 degradation and transactivational silencing (21,22). The INK4A is altered in many cell lines and primary tumors (23–26). Furthermore, germ line mutations of the INK4A gene are found on patients with familial melanoma and pancreatic adenocarcinoma (27–28); and targeted deletion of the INK4A in murine models is associated with the development of spontaneous tumors (29,30).
Genomic organization of the INK4A and INK4B gene locus.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Sherr, C. J. (1996) Cancer cell cycles. Science 274, 1672–1677.
Clurman, B. E. and Roberts, J. M. (1995) Cell cycle and cancer. J. Natl. Cancer Inst. 87, 1499–1501.
Cordón-Cardó, C. (1995) Mutation of cell cycle regulators. Am. J. Pathol. 147, 545–559.
El-Deiry, W. S., Tokino, T., Velculescu, V. E., Levy, D. B., Parsons, R., Trent, J. M., et al. (1993) WAF1, a potential mediator of p53 tumor suppression. Cell 75, 817–825.
Harper, J. W., Adami, G. R., Wei, N., Keyomarsi, K., and Elledge, S. J. (1993) The p21 cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases. Cell 75, 805–816.
Xiong, Y., Hannon, G. J., Zhang, H., Casso, D., Kobayashi, R., and Beach, D. (1993) p21 is a universal inhibitor of cyclin kinases. Nature 366, 701–704.
Polyak, K., Kato, J. Y., Solomon, M. J., Sherr, C. J., Massague, J., Roberts, J. M., et al. (1994) p27Kip1, a cyclin-Cdk inhibitor, links transforming growth factor-beta and contact inhibition to cell cycle arrest. Genes Dev. 8, 9–22.
Toyoshima, H. and Hunter, T. (1994) p27, a novel inhibitor of G1 cyclin-cdk protein kinase activity, is related to p21. Cell 78, 67–74.
Ponce-Castañeda, V. M., Lee, M. H., Latres, E., Polyak, K., Lacombe, L., Montgomery, K., et al. (1995) p27 Kip1: chromosomal mapping to 12p12–12p13.1 and absence of mutations in human tumors. Cancer Res. 55,1211–1214.
Lee, M.-H, Reynisdóttir, I., and Massague, J. (1995) Cloning of p57KIP2, a cyclin-dependent kinase inhibitor with unique domain structure and tissue distribution. Genes Dev. 9, 639–649.
Matsuoka, S., Edwards, M. C., Bai, C., Parker, S., Zhang, P., Baldini, A. (1995) p57KIP2, a structurally distinct member of the p21CIP1 Cdk inhibitory family, is a candidate tumor suppressor gene. Genes Dev. 9, 650–662.
Serrano, M., Hannon, G. J., and Beach, D. (1993) A new regulatory motif in cell cycle control causing specific inhibition of cyclin D/CDK4. Nature 366, 704–707.
Kamb, A., Gruis, N. A., Weaver Feldhaus, J., Liu, Q., Harshman, K., Tavtigian, S. V., et al. (1994) A cell cycle regulator potentially involved in genesis of many tumor types. Science 264, 436–440.
Hannon, G. J. and Beach, D. (1994) p15 INK4B is a potential effector of TGFβ-induced cell cycle arrest. Nature 371, 257–261.
Guan, K. L., Jenkins, C. W., Li, Y., Nichols, M. A., Wu, X., and O’Keefe, C. L. (1994) Growth suppression by p18, a p16INK4/MTS1 and p14INK4B/MTS2a-related CDK6 inhibitor, correlates with wild-type pRB function. Genes Dev. 8, 2939–2952.
Okuda, T., Hirai, H., Valentine, V. A., Shurtleff, S. A., Kidd, V. J., and Lahti, J. M. (1995) Molecular cloning, expression pattern, and chromosomal localization of human CDKN2D/INK4D, an inhibitor of cyclin D-dependent kinases. Genomics 29, 623–630.
Quelle, D. E., Zindy, F., Ashmun, R. A., and Sherr, C. J. (1995) Alternative reading frames of the INK4a tumor suppressor gene encode two unrelated proteins capable of inducing cell cycle arrest. Cell 83, 993–1000.
Duro, D., Bernard, O., Della Valle, V., Berger, R., and Larsen, C. J. (1995) A new type of p16INK4/MTS1 gene transcript expressed in B-cell malignancies. Oncogene 11, 21–29.
Mao, L., Merlo, A., Bedi, G., Shapiro, G. I., Edwards, C. D., and Rollins, B. J. (1995) A novel p16INK4A transcript. Cancer Res. 55, 2995–2997.
Stone, S., Jiang, P., Dayananth, P., Tavtigian, S. V., Katcher, H., and Parry, D. (1995) Complex structure and regulation of the P16 (MTS1) locus. Cancer Res. 55, 2988–2994.
Pomerantz, J., Schrieber-Agus, N., Liegoeis, N., Silverman, A., Alland, L., and Chin, L. (1998) The Ink4a tumor suppressor gene product, p19Arf, interacts with MDM2 and neutralizes MDM2’s inhibition of p53. Cell 92, 713–723.
Zhang, Y., Xiong, Y., and Yarbrough, W. G. (1998) ARF promotes MDM2 degradation and stabilizes p53: ARF-INK4a locus deletion impairs both the Rb and p53 tumor suppression pathways. Cell 92, 725–734.
Jen, J., Harper, J. W., Bigner, S. H., Bigner, D. D., Papadopoulos, N., Markowitz, S., et al. (1994) Deletion of p16 and p15 genes in brain tumors. Cancer Res. 54, 6353–6358.
Spruck, C. H. III, Gonzalez-Zulueta, M., Shibata, A., Simoneau, A. R., Lin, M. F., Gonzales, F., et al. (1994) p16 gene in uncultured tumours. Nature 370, 183–184.
Gruis, N. A., Weaver-Feldhaus, J., Liu, Q., Frye, C., Eeles, R., Orlow, I., et al. (1995) Genetic evidence in melanoma and bladder cancers that p16 and p53 function in separate pathways of tumor suppression. Am. J. Pathol. 146, 1199–1206.
Reed, A. L., Califano, J., Cairns, P., Westra, W. H., Jones, R. M., Koch, W., et al. (1996) High frequency of p16 (CDKN2/MTS-1/INK4A) inactivation in head and neck squamous cell carcinoma. Cancer Res. 56, 3630–3633.
Hussussian, C. J., Struewing, J. P., Goldstein, A. M., Higgins, P. A., Ally, D. S., Sheahan, M. D., Clark, W. H. Jr, et al. (1994) Germline p16 mutations in familial melanoma. Nat. Genet. 8, 15–21.
Goldstein, A. M., Fraser, M. C., Struewing, J. P., Hussussian, C. J., Ranade, K., Zametkin, D. P., et al. (1995) Increased risk of pancreatic cancer in melanoma-prone kindreds with p16INK4 mutations. N. Engl. J. Med. 333, 970–974.
Serrano, M., Lee, H.-W., Chin, L., Cordon-Cardo, C., Beach, D., and DePinho, R. (1996) Role of the INK4a locus in tumor suppression and cell mortality. Cell 85, 27–37.
Kamijo, T., Zindy, F., Roussel, M. F., Quelle, D. E., Downing, J. R., Ashmun, R. A., et al. (1997) Tumor suppression at the mouse INK4a locus mediated by the alternative reading frame product p19ARF. Cell 91, 649–659.
Orlow, I., Lianes, P., Lacombe, L., Dalbagni, G., Reuter, V. E., and Cordon-Cardo, C. (1994) Chromosome 9 allelic losses and microsatellite alterations in human bladder tumors. Cancer Res. 54, 2848–2851.
Orlow, I., Lacombe, L., Hannon, G. J., Serrano, M., Pellicer, I., Dalbagni, G., et al. (1995) Deletion of the p16 and p15 genes in human bladder tumors. J. Natl. Cancer Inst. 87, 1524–1529.
Orlow, I., LaRue, H., Osman, I., Lacombe, L., Moore, L., Rabbani, F., et al. (1999) Deletions of the INK4A gene in superficial bladder tumors. Association with recurrence. Am. J. Pathol. 155, 105–113.
Southern, E. M. (1975) Detection of specific sequences among DNA fragments separated by gel electrophoresis. J. Mol. Biol. 98, 503–517.
Zariwala, M., Liu, E., and Xiong, Y. (1996) Mutational analysis of the p16 family cyclin-dependent kinase inhibitors p15ink4b and p18ink4c in tumor derived cell lines and primary tumors. Oncogene 12, 451–455.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2002 Humana Press Inc.
About this protocol
Cite this protocol
Orlow, I., Cordon-Cardo, C. (2002). Evaluation of Alterations in the Tumor Suppressor Genes INK4A and INK4B in Human Bladder Tumors. In: de Muro, M.A., Rapley, R. (eds) Gene Probes. Methods in Molecular Biology, vol 179. Humana Press, Totowa, NJ. https://doi.org/10.1385/1-59259-238-4:043
Download citation
DOI: https://doi.org/10.1385/1-59259-238-4:043
Publisher Name: Humana Press, Totowa, NJ
Print ISBN: 978-0-89603-885-1
Online ISBN: 978-1-59259-238-8
eBook Packages: Springer Protocols